194 related articles for article (PubMed ID: 21731677)
1. Daidzein prevents the increase in CD4+CD28null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect.
Tyagi AM; Srivastava K; Sharan K; Yadav D; Maurya R; Singh D
PLoS One; 2011; 6(6):e21216. PubMed ID: 21731677
[TBL] [Abstract][Full Text] [Related]
2. Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss.
Tyagi AM; Srivastava K; Kureel J; Kumar A; Raghuvanshi A; Yadav D; Maurya R; Goel A; Singh D
Osteoporos Int; 2012 Mar; 23(3):1151-61. PubMed ID: 21562872
[TBL] [Abstract][Full Text] [Related]
3. Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-α antibodies.
Tyagi AM; Mansoori MN; Srivastava K; Khan MP; Kureel J; Dixit M; Shukla P; Trivedi R; Chattopadhyay N; Singh D
J Bone Miner Res; 2014 Sep; 29(9):1981-92. PubMed ID: 24677326
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
5. Methoxyisoflavones formononetin and isoformononetin inhibit the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions.
Mansoori MN; Tyagi AM; Shukla P; Srivastava K; Dev K; Chillara R; Maurya R; Singh D
Menopause; 2016 May; 23(5):565-76. PubMed ID: 27070807
[TBL] [Abstract][Full Text] [Related]
6. Bu‑Shen‑Ning‑Xin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4+ T lymphocytes of ovariectomized mice.
Zhang JL; Qiu XM; Zhang N; Tang W; Gober HJ; Li DJ; Wang L
Int J Mol Med; 2018 Jul; 42(1):299-308. PubMed ID: 29717766
[TBL] [Abstract][Full Text] [Related]
7. Turbo methanol extract inhibits bone resorption through regulation of T cell function.
Balakrishnan B; Indap MM; Singh SP; Krishna CM; Chiplunkar SV
Bone; 2014 Jan; 58():114-25. PubMed ID: 24140785
[TBL] [Abstract][Full Text] [Related]
8. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.
Sun D; Krishnan A; Zaman K; Lawrence R; Bhattacharya A; Fernandes G
J Bone Miner Res; 2003 Jul; 18(7):1206-16. PubMed ID: 12854830
[TBL] [Abstract][Full Text] [Related]
9. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice.
Onoe Y; Miyaura C; Ito M; Ohta H; Nozawa S; Suda T
J Bone Miner Res; 2000 Mar; 15(3):541-9. PubMed ID: 10750569
[TBL] [Abstract][Full Text] [Related]
11. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
12. Selective effects of genistein, a soybean isoflavone, on B-lymphopoiesis and bone loss caused by estrogen deficiency.
Ishimi Y; Miyaura C; Ohmura M; Onoe Y; Sato T; Uchiyama Y; Ito M; Wang X; Suda T; Ikegami S
Endocrinology; 1999 Apr; 140(4):1893-900. PubMed ID: 10098529
[TBL] [Abstract][Full Text] [Related]
13. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
[TBL] [Abstract][Full Text] [Related]
14. Influence of estrogen deficiency and replacement on T-cell populations in rat lymphoid tissues and organs.
Safadi FF; Dissanayake IR; Goodman GG; Jago RA; Baker AE; Bowman AR; Sass DA; Popoff SN; Epstein S
Endocrine; 2000 Feb; 12(1):81-8. PubMed ID: 10855695
[TBL] [Abstract][Full Text] [Related]
15. α-Linolenic Acid Inhibits Receptor Activator of NF-κB Ligand Induced (RANKL-Induced) Osteoclastogenesis and Prevents Inflammatory Bone Loss via Downregulation of Nuclear Factor-KappaB-Inducible Nitric Oxide Synthases (NF-κB-iNOS) Signaling Pathways.
Song J; Jing Z; Hu W; Yu J; Cui X
Med Sci Monit; 2017 Oct; 23():5056-5069. PubMed ID: 29061958
[TBL] [Abstract][Full Text] [Related]
16. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
[TBL] [Abstract][Full Text] [Related]
17. Generation of bone-resorbing osteoclasts from B220+ cells: its role in accelerated osteoclastogenesis due to estrogen deficiency.
Sato T; Shibata T; Ikeda K; Watanabe K
J Bone Miner Res; 2001 Dec; 16(12):2215-21. PubMed ID: 11760834
[TBL] [Abstract][Full Text] [Related]
18. Comparative activities of daidzein metabolites, equol and O-desmethylangolensin, on bone mineral density and lipid metabolism in ovariectomized mice and in osteoclast cell cultures.
Ohtomo T; Uehara M; Peñalvo JL; Adlercreutz H; Katsumata S; Suzuki K; Takeda K; Masuyama R; Ishimi Y
Eur J Nutr; 2008 Aug; 47(5):273-9. PubMed ID: 18622636
[TBL] [Abstract][Full Text] [Related]
19. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
[TBL] [Abstract][Full Text] [Related]
20. BMI-1 Mediates Estrogen-Deficiency-Induced Bone Loss by Inhibiting Reactive Oxygen Species Accumulation and T Cell Activation.
Li J; Wang Q; Yang R; Zhang J; Li X; Zhou X; Miao D
J Bone Miner Res; 2017 May; 32(5):962-973. PubMed ID: 27943387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
